Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP516682.RAKMWTFSFQtCrpBsZbVFqs3febP4Nh0t-FQI_QFFynLOs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP516682.RAKMWTFSFQtCrpBsZbVFqs3febP4Nh0t-FQI_QFFynLOs130_assertion type Assertion NP516682.RAKMWTFSFQtCrpBsZbVFqs3febP4Nh0t-FQI_QFFynLOs130_head.
- NP516682.RAKMWTFSFQtCrpBsZbVFqs3febP4Nh0t-FQI_QFFynLOs130_assertion description "[Thus, ING1 mutation is very rare in breast or ovarian cancers, however, repression of ING1 expression frequently accompanies tumour development of breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP516682.RAKMWTFSFQtCrpBsZbVFqs3febP4Nh0t-FQI_QFFynLOs130_provenance.
- NP516682.RAKMWTFSFQtCrpBsZbVFqs3febP4Nh0t-FQI_QFFynLOs130_assertion evidence source_evidence_literature NP516682.RAKMWTFSFQtCrpBsZbVFqs3febP4Nh0t-FQI_QFFynLOs130_provenance.
- NP516682.RAKMWTFSFQtCrpBsZbVFqs3febP4Nh0t-FQI_QFFynLOs130_assertion SIO_000772 10498868 NP516682.RAKMWTFSFQtCrpBsZbVFqs3febP4Nh0t-FQI_QFFynLOs130_provenance.
- NP516682.RAKMWTFSFQtCrpBsZbVFqs3febP4Nh0t-FQI_QFFynLOs130_assertion wasDerivedFrom befree-20140225 NP516682.RAKMWTFSFQtCrpBsZbVFqs3febP4Nh0t-FQI_QFFynLOs130_provenance.
- NP516682.RAKMWTFSFQtCrpBsZbVFqs3febP4Nh0t-FQI_QFFynLOs130_assertion wasGeneratedBy ECO_0000203 NP516682.RAKMWTFSFQtCrpBsZbVFqs3febP4Nh0t-FQI_QFFynLOs130_provenance.